A new study has found that astronauts’ brains can be repositioned and reshaped during stints in outer space. Published in the ...
Everyday Health on MSN
There’s a new drug for motion sickness — the first in 40 years
The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...
Tradipitant is a selective human substance P/neurokinin-1 receptor antagonist approved for the prevention of vomiting induced by motion in adults.
Don’t tell Neil Armstrong, but giant leaps for mankind may leave astronauts feeling a little queasy. In a new experiment, aerospace engineers at the University of Colorado Boulder will work with ...
Jefferies analysts envision a steady launch curve that could ultimately drive meaningful sales from people who are ...
FDA approval of Vanda’s Nereus marks a rare and meaningful regulatory milestone, introducing the first new pharmacologic ...
Analysts raise price targets for Vanda Pharmaceuticals after FDA approved a motion sickness drug, citing growth potential.
A combination of physiological, neurological, genetic, and habit-linked factors influences how prone one is to feeling motion ...
Motion sickness sufferers will know all too well how feelings of nausea can linger even after movement has stopped. But researchers in China may have found a way to speed up recovery — listen to happy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback